Sysmex Corporation (SSMXY)
USD 18.76
(-0.27%)
USD 18.76
(-0.27%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 49.63 Billion JPY | 8.42% |
| 2023 | 45.78 Billion JPY | 3.84% |
| 2022 | 44.09 Billion JPY | 38.2% |
| 2021 | 31.9 Billion JPY | -8.54% |
| 2020 | 34.88 Billion JPY | -15.38% |
| 2019 | 41.22 Billion JPY | 5.11% |
| 2018 | 39.22 Billion JPY | -3.48% |
| 2017 | 40.63 Billion JPY | 3.45% |
| 2016 | 39.27 Billion JPY | 47.45% |
| 2015 | 26.63 Billion JPY | 29.48% |
| 2014 | 20.57 Billion JPY | 45.24% |
| 2013 | 14.16 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 8.62 Billion JPY | -18.67% |
| 2024 Q2 | 13.56 Billion JPY | 57.37% |
| 2024 Q3 | 12.27 Billion JPY | -9.5% |
| 2024 FY | 49.63 Billion JPY | 8.42% |
| 2024 Q4 | 15.17 Billion JPY | 23.61% |
| 2023 Q2 | 15.95 Billion JPY | 98.74% |
| 2023 FY | 45.78 Billion JPY | 3.84% |
| 2023 Q4 | 10.59 Billion JPY | -5.32% |
| 2023 Q3 | 11.19 Billion JPY | -29.86% |
| 2023 Q1 | 8.03 Billion JPY | -28.25% |
| 2022 Q3 | 10.65 Billion JPY | -13.0% |
| 2022 Q2 | 12.25 Billion JPY | 22.6% |
| 2022 FY | 44.09 Billion JPY | 38.2% |
| 2022 Q1 | 9.99 Billion JPY | 1.4% |
| 2022 Q4 | 11.19 Billion JPY | 5.01% |
| 2021 Q2 | 8.16 Billion JPY | 81.99% |
| 2021 FY | 31.9 Billion JPY | -8.54% |
| 2021 Q3 | 10.63 Billion JPY | 30.22% |
| 2021 Q1 | 4.48 Billion JPY | -46.5% |
| 2021 Q4 | 9.85 Billion JPY | -7.33% |
| 2020 Q4 | 8.38 Billion JPY | -5.79% |
| 2020 FY | 34.88 Billion JPY | -15.38% |
| 2020 Q3 | 8.9 Billion JPY | -18.3% |
| 2020 Q2 | 10.89 Billion JPY | 62.7% |
| 2020 Q1 | 6.69 Billion JPY | -45.63% |
| 2019 Q3 | 9.43 Billion JPY | -6.13% |
| 2019 FY | 41.22 Billion JPY | 5.11% |
| 2019 Q1 | 9.42 Billion JPY | 8.73% |
| 2019 Q2 | 10.04 Billion JPY | 6.63% |
| 2019 Q4 | 12.31 Billion JPY | 30.57% |
| 2018 Q3 | 11.36 Billion JPY | 3.55% |
| 2018 FY | 39.22 Billion JPY | -3.48% |
| 2018 Q1 | 8.22 Billion JPY | -5.18% |
| 2018 Q4 | 8.66 Billion JPY | -23.72% |
| 2018 Q2 | 10.97 Billion JPY | 33.48% |
| 2017 Q2 | 14.03 Billion JPY | 48.53% |
| 2017 Q3 | 8.48 Billion JPY | -39.57% |
| 2017 Q4 | 8.66 Billion JPY | 2.2% |
| 2017 FY | 40.63 Billion JPY | 3.45% |
| 2017 Q1 | 9.44 Billion JPY | 3.29% |
| 2016 FY | 39.27 Billion JPY | 47.45% |
| 2016 Q3 | 10.27 Billion JPY | 10.5% |
| 2016 Q2 | 9.3 Billion JPY | 23.91% |
| 2016 Q1 | 7.5 Billion JPY | 24.73% |
| 2016 Q4 | 9.14 Billion JPY | -10.99% |
| 2015 Q1 | 5.18 Billion JPY | -21.06% |
| 2015 Q4 | 6.01 Billion JPY | -23.7% |
| 2015 Q3 | 7.88 Billion JPY | 4.52% |
| 2015 Q2 | 7.54 Billion JPY | 45.48% |
| 2015 FY | 26.63 Billion JPY | 29.48% |
| 2014 Q2 | 5.52 Billion JPY | 80.23% |
| 2014 FY | 20.57 Billion JPY | 45.24% |
| 2014 Q4 | 6.57 Billion JPY | 21.46% |
| 2014 Q3 | 5.41 Billion JPY | -2.1% |
| 2014 Q1 | 3.06 Billion JPY | -34.02% |
| 2013 Q3 | 3.13 Billion JPY | -23.3% |
| 2013 Q2 | 4.08 Billion JPY | 0.0% |
| 2013 FY | 14.16 Billion JPY | 0.0% |
| 2013 Q4 | 4.64 Billion JPY | 48.47% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 5355518.587% |
| Ansell Limited | 76.5 Million USD | -64787.582% |
| Ansell Limited | 76.5 Million USD | -64787.582% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -204342.303% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 3044983.493% |
| Psykey, Inc. | -1.32 Million USD | 3749407.943% |
| ConvaTec Group Plc | 130.3 Million USD | -37995.932% |
| ConvaTec Group Plc | 130.3 Million USD | -37995.932% |
| Encision Inc. | -691.78 Thousand USD | 7175616.022% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 35003731.594% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 21180219.983% |
| Innovative MedTech Inc. | -7.93 Million USD | 625363.182% |
| LifePoint, Inc. | -15.23 Million USD | 325994.914% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 728906.343% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 10472462.869% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 18087082.503% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 10814037.276% |
| SmileDirectClub, Inc. | -86.4 Million USD | 57549.887% |
| Sector 10, Inc. | 7036.00 USD | -705500184.252% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | -2379.587% |
| SheerVision, Inc. | -71.37 Thousand USD | 69545885.698% |
| United Health Products, Inc. | -2.62 Million USD | 1892358.775% |
| Vasamed, Inc. | -4.88 Million USD | 1015596.037% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 2078378.662% |
| Yubo International Biotech Limited | -1.2 Million USD | 4120322.616% |